Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

NBIX — Neurocrine Biosciences, Inc.

UNDERVALUED (MOS +25.6%) · Quality 76/100

Value Score 30 days ago: 52.8 → today 31.1

NBIX - Neurocrine Biosciences, Inc.
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 174.41 USD
Intrinsic value: 234.41 USD
Margin of safety: +25.6%
Implied growth (reverse DCF): +7.0% (model assumes +13.8%)
Valuation: UNDERVALUED
Value Score: 31.1
Quality: 76/100
Moat score: 67.5 (erosion: none)
UNDERVALUED (MOS +25.6%) - Quality 76/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/NBIX
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

174.41

Intrinsic value

234.41

Margin of safety

+25.6%

Implied growth (reverse DCF)

+7.0%

model assumes +13.8%

Value Score

31.1

Quality

Psychology

-40.5

Discovery

13.8

price/volume attention only

Moat score

67.5

erosion: none

Value Score: top 34% of Russell 3000 · Quality: top 17%

Open the interactive Deep Dive for NBIX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/NBIX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is NBIX undervalued?

As of 2026-11-11, NBIX trades at 174.41 against a computed intrinsic value of 234.41 (+25.6% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Neurocrine Biosciences, Inc.'s Value Score?

Neurocrine Biosciences, Inc.'s Value Score is 31.1 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.